I CFD sono strumenti complessi e presentano un alto rischio di perdere soldi rapidamente a causa della leva finanziaria. Il 74% dei conti di clienti al dettaglio perde denaro facendo trading con i CFD con questo fornitore. Devi verificare se comprendi pienamente come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.

Close

Fai trading su JnJ JNJ

Grafico live di JnJ

Fondamentali dello strumento

Weekly Search
Weekly
Daily
Data Chiudi Variazione variazione % Apertura Massimo Minimo

Le ultime notizie

Closing 2024
2024 Dec 26, 17:00

La prossima settimana:Chiusura del 2024 e primi dati economici del 2025

Forex Indici
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

La prossima settimana: Ultima settimana del 2024 sui mercati finanziari

Forex Indici
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

La prossima settimana: I tassi di interesse USA e l’inflazione in Europa determineranno la direzione dei mercati

Forex Indici
Dyogenes Diniz 2024 Dec 05, 16:00

La prossima settimana: L’inflazione e i tassi di interesse condizioneranno i mercati questa settimana

Forex Indici
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

La prossima settimana: L’occupazione USA probabilmente guiderà il sentiment sul mercato questa settimana.

Forex Indici
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

La prossima settimana: I dati sull’inflazione nell’area euro probabilmente confermeranno il taglio di dicembre dei tassi della BCE

Forex Indici
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

L’importante rally dei titoli del tech in parte dipenderà dalle trimestrali di Nvidia che verranno pubblicate mercoledì.

Forex Indici
Markets.com Support Team 2024 Nov 07, 16:00

La prossima settimana: Trump trade, dati sull’inflazione e trimestrali di Disney

Forex Indici

Informazioni

Spread

0.95

Spread (%)

0.6419 %

Leva

1:2

Interesse overnight acquisto

-0.0597 %

Interesse overnight vendita

-0.0292 %

Valuta

USD

Orari di trading

Markets closed

Venerdì

13:31 - 19:59

Lunedì

13:31-19:59

Martedì

13:31-19:59

Mercoledì

13:31-19:59

Giovedi

13:31-19:59

Analisi e statistiche

Apertura

---

Chiusura precedente

---

Massimo/Minimo di 52 settimane

--- – ---

Capitalizzazione di mercato

365646544896

Azioni in circolazione

2409850112

Data delle trimestrali (prossima)

2001-06-13

Rendimento da dividendo

2025-03-04

Data ex dividendo

2025-02-18

Tasso di dividendo annuale a termine

4.96

Rendimento del dividendo annuale a termine

0.0327

EPS

5.8

Scopri di più su questo strumento

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Strumenti correlati

Strumenti correlati
Trustpilot
SettingsRequest history38.1.18PHP Version15.03msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
15.26ms
peak_memory
2MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
0 of 0
array:14 [ "cookie" => array:1 [ 0 => "mktv4_ip_override=en; XSRF-TOKEN=eyJpdiI6ImpWM01Id1FweDd3N1pIMjFGTGJpblE9PSIsInZhbHVlIjoiYjFJYlNnU3dhUFZDaHBxOEJqSjdkTXFhQ2hDc1RvN2ltR0oyUmZvQ1d0YVBZQm5XbGwxSU1udG9oUExRL2IyTXVKQUZtZEpzQ3huUWUxVEVRSzlrekI5M3hvSk51MGNXSEY2UmR4STkrYUp3SUhWUWZFNkxFbnpYQmwyd1ZYbUsiLCJtYWMiOiJkMTdlN2NhY2RhOWMxYTNmNDZmNmVhNGFlMDFkYThjNDRlNjUwMDY4ZDAyOGJlZDMxY2VjYWYxNzI2NGRlZDYwIiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6ImlvemczVENhZWlydldmdExmWFFlOFE9PSIsInZhbHVlIjoid3REQTZITTVrTzhtRFpqa2NjWU5LMGUvVHlCQ09xa0FwRkVEOU1mcWY4ZEhsZFU1WUJhWHhuSmxrVEVTdU9Vdi9aMk5qeHFhc2l1UXo5Q3lHcWsvZTVVb3MwL1poNmcrRm0xc08zRnpNcnFTeFMvTFJhOVVpbjRLZ0xpem1aYTMiLCJtYWMiOiI4NjdmNjcwZGRiMzU0MTQ0YmU3ZmNmNmNkZjU0ZTdmNGVlZjQyZGY0NzFhYjU0YTk5Y2VkMWIxYzc1ZDJiYjM1IiwidGFnIjoiIn0%3D; mktloc=eyJpdiI6IjA2MTF0eTBUdnhQM2NuaFJRUG8wQVE9PSIsInZhbHVlIjoidG5BUlNyLzg0a3JEOHBTRlJRNUtXZmRhVEVkUlQwUGhwTVJEWktYcSs1N0dabk9NNjJ4czJQcnpHaVVPWTFrRSIsIm1hYyI6IjhkNjg2YjQ1MzlmY2IzNGU4YjhmNTJlYjZjZDY0NmNjZWQ5NWNmMDhkMTk5MzY3ZDRlMjVkNGZmNjFlMGI3ODYiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fsv%252Finstrument%252Fnio%252F; intent_instrument=niomktv4_ip_override=en; XSRF-TOKEN=eyJpdiI6ImpWM01Id1FweDd3N1pIMjFGTGJpblE9PSIsInZhbHVlIjoiYjFJYlNnU3dhUFZDaHBxOEJqSjdkTXFhQ2hDc1RvN2ltR0oyUmZvQ1d0YVBZQm5XbGwxSU1" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate, br, zstd" ] "sec-fetch-dest" => array:1 [ 0 => "empty" ] "sec-fetch-mode" => array:1 [ 0 => "cors" ] "sec-fetch-site" => array:1 [ 0 => "same-origin" ] "accept" => array:1 [ 0 => "*/*" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "web-qa.staging.markets.com" ] ]
request_cookies
0 of 0
array:6 [ "mktv4_ip_override" => null "XSRF-TOKEN" => "e1Du9A42rLCgk3WyLwqpW9YHUALAlIcL4mRjJ82C" "laravel_session" => "KBNs9DQA7MnZJRwgG6pxhsKOWBzWHBiifB50X645" "mktloc" => "us,us" "intent_group" => null "intent_instrument" => null ]
response_headers
0 of 0
array:3 [ "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 15 Apr 2025 02:40:14 GMT" ] "content-type" => array:1 [ 0 => "application/json" ] ]
session_attributes
0 of 0
array:4 [ "_token" => "e1Du9A42rLCgk3WyLwqpW9YHUALAlIcL4mRjJ82C" "PHPDEBUGBAR_STACK_DATA" => [] "_previous" => array:1 [ "url" => "https://web-qa.staging.markets.com/en/instrument/ewy" ] "_flash" => array:2 [ "old" => [] "new" => [] ] ]
    • Booting (12.66ms)time
    • Application (2.36ms)time
    • Routing (480μs)
    • 1 x Booting (84.21%)
      12.66ms
      1 x Application (15.72%)
      2.36ms
      1 x Routing (3.19%)
      480μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              e1Du9A42rLCgk3WyLwqpW9YHUALAlIcL4mRjJ82C
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/en/instrument/ewy" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-15 02:40:12GET/it/instrument/jnj/967
              #22025-04-15 02:40:14GET/csrf/ (ajax)
              #32025-04-15 02:40:14GET/params/ (ajax)